Dr. Daniel Kim, M.D.
Interventional Radiology (Vascular & Interventional Radiology Physician)
2125 Oak Grove Rd, Suite 200
Walnut Creek, CA 94598
Who else practices at this address →
Contra Costa County includes mental health (19% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Maryland School of Medicine (2005)
- Years since graduation
- 21
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 1,493
Licensed in California since 2012, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Medical school: University of Maryland School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Vascular & Interventional Radiology Physician primary
CA license A123474 (first issued 2012; current) -
Diagnostic Radiology Physician
CA license A123474 (first issued 2012; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- John Muir Medical Center - Walnut Creek Campus Walnut Creek, CA
- Alta Bates Summit Medical Center Oakland, CA
- John Muir Medical Center - Concord Campus Concord, CA
- Contra Costa Regional Medical Center Martinez, CA
- UCSF Health Saint Francis Hospital San Francisco, CA
Medical groups
- Bay Imaging Consultants Medical Group Inc (146 clinicians)
- John Muir Trauma Physicians Billing Service (113 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,493
- Services billed
- 2,511
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| X-ray of chest, 1 view | 194 | 190 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 179 | 171 |
| X-ray of chest, 2 views | 60 | 60 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 59 | 55 |
| Ultrasonic guidance for blood vessel access | 59 | 56 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 54 | 54 |
| Review by radiologist of ct guidance for needle placement | 45 | 44 |
| Ct scan of blood vessels of abdomen and pelvis with contrast | 44 | 44 |
| Drainage of fluid from abdominal cavity using imaging guidance | 43 | 28 |
| Ct scan of chest without contrast | 43 | 43 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 1 companies reported 2 payments worth $242 in total to this clinician.
| Penumbra, Inc. | $242 |
|---|
| Food and Beverage | $242 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $5,485 in research payments for these studies, mostly to the institutions running them.
- A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Maridebart Cafraglutide on Mortality and Morbidity in Participants Living With Heart Failure With Preserved or Mildly…
Amgen Inc. - A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants With Elevated Lipoprotein(a)
Amgen Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.